Search Results - "Cacheux, Victoria"

Humoral immune-depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma by Bouard, Louise, Tessoulin, Benoit, Thieblemont, Catherine, Bouabdallah, Kamal, Gastinne, Thomas, Oberic, Lucie, Carras, Sylvain, Delette, Caroline, Casasnovas, Olivier, Dartigeas, Caroline, Cacheux, Victoria, Masse, Sibylle, Hermine, Olivier, Le Gouill, Steven

“…Rituximab maintenance (RM) after autologous stem cell transplantation (ASCT) is standardof-care for young patients with mantle cell lymphoma (MCL). RM may…”
Get full text

Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes by Ouedraogo, Zangbéwendé Guy, Cacheux, Victoria, Dannus, Louis‐Thomas, Dupre, Nathalie, Veronese, Lauren, Lebecque, Benjamin

Get full text

Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire by GARNIER, Alice, ROBIN, Marie, DREYFUS, Brigitte, DREGER, Peter, RIO, Bernard, MOLES-MOREAU, Marie-Pierre, BILGER, Karin, BAY, Jacques-Olivier, LEBLOND, Véronique, BLAISE, Didier, TOURNILHAC, Olivier, DHEDIN, Nathalie, LAROSA, Fabrice, GOLMARD, Jean-Louis, LE GOUILL, Steven, COITEUX, Valérie, TABRIZI, Reza, BULABOIS, Claude-Eric, CACHEUX, Victoria, KUENTZ, Mathieu

“…Patients with poor-risk Waldenström's macroglobulinemia have suboptimal response and early post-treatment relapse with conventional therapies. Hence, new…”
Get full text

Epcoritamab – lymphome B diffus à grandes cellules récidivant ou réfractaire après au moins deux lignes de traitement systémique by Bensaber, Hedi, Cacheux, Victoria

Get full text

Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma by Sarkozy, Clémentine, Callanan, Mary, Thieblemont, Catherine, Obéric, Lucie, Burroni, Barbara, Bouabdallah, Krimo, Damaj, Gandhi, Tessoulin, Benoit, Ribrag, Vincent, Houot, Roch, Morschhauser, Franck, Griolet, Samuel, Joubert, Clémentine, Cacheux, Victoria, Delwail, Vincent, Safar, Violaine, Gressin, Remy, Cheminant, Morgane, Delfau-Larue, Marie-Hélène, Hermine, Olivier, Macintyre, Elizabeth, Le Gouill, Steven

“…•O can safely be used in combination with chemotherapy and in maintenance after ASCT as frontline therapy in patients with MCL.•O provides better disease…”
Get full text

Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients by Sarkozy, Clémentine, Callanan, Mary Bridgid, Thieblemont, Catherine, Obéric, Lucie, Burroni, Barbara, Bouabdallah, Krimo, Damaj, Ghandi, Tessoulin, Benoit, Ribrag, Vincent, Houot, Roch, Morschhauser, Franck, Griolet, Samuel, Joubert, Clémentine, Cacheux, Victoria, Delwail, Vincent, Safar, Violaine, Gressin, Remy, Cheminant, Morgane, Delfau-Larue, Marie-Helene, Hermine, Olivier, Macintyre, Elizabeth A., Le Gouill, Steven

“…Obinutuzumab (O) and Rituximab (R) are two CD antibodies that have never been compared in a prospective randomised trial in mantle cell lymphoma (MCL). Herein,…”
Get full text

Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study by Orvain, Corentin, Balsat, Marie, Tavernier, Emmanuelle, Marolleau, Jean-Pierre, Pabst, Thomas, Chevallier, Patrice, de Gunzburg, Noémie, Cacheux, Victoria, Huguet, Françoise, Chantepie, Sylvain, Caillot, Denis, Chalandon, Yves, Frayfer, Jamilé, Bonmati, Caroline, Lheritier, Véronique, Ifrah, Norbert, Dombret, Hervé, Boissel, Nicolas, Hunault-Berger, Mathilde

“…Patients undergoing treatment of acute lymphoblastic leukemia (ALL) are at risk for thrombosis, caused in part by the use of l-asparaginase (L-ASP)…”
Get full text

Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study by Kim, Rathana, Chalandon, Yves, Rousselot, Philippe, Cayuela, Jean-Michel, Huguet, Françoise, Balsat, Marie, Passet, Marie, Chevallier, Patrice, Hicheri, Yosr, Raffoux, Emmanuel, Leguay, Thibaut, Chantepie, Sylvain, Maury, Sébastien, Hayette, Sandrine, Solly, Françoise, Braun, Thorsten, De Prijck, Bernard, Cacheux, Victoria, Salanoubat, Celia, Farnault, Laure, Guibaud, Isabelle, Lamarque, Mathilde, Gastaud, Lauris, Lemasle, Emilie, Brissot, Eolia, Tavernier, Emmanuelle, Bilger, Karine, Villate, Alban, Soulier, Jean, Graux, Carlos, Lhéritier, Véronique, Dombret, Hervé, Boissel, Nicolas, Clappier, Emmanuelle

“…quantification is widely regarded as the standard for monitoring measurable residual disease (MRD) in Philadelphia chromosome-positive (Ph+) ALL. However,…”
Get full text

Faster clinical decisions in B‐cell acute lymphoblastic leukaemia: A single flow cytometric 12‐colour tube improves diagnosis and minimal residual disease follow‐up by Lebecque, Benjamin, Besombes, Joevin, Dannus, Louis‐Thomas, De Antonio, Marie, Cacheux, Victoria, Grèze, Victoria, Montagnon, Valentin, Veronese, Lauren, Tchirkov, Andrei, Tournilhac, Olivier, Berger, Marc G., Veyrat‐Masson, Richard

“…Summary Assessing minimal residual disease (MRD) in B‐cell precursor acute lymphoblastic leukaemia (BCP‐ALL) is essential for adjusting therapeutic strategies…”
Get full text

Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials by Sarkozy, Clementine, Callanan, Mary, Thieblemont, Catherine, Oberic, Lucie, Burroni, Barbara, Bouabdallah, Krimo, Damaj, Gandhi Laurent, Tessoulin, Benoit, Ribrag, Vincent, Houot, Roch, Morschhauser, Franck, Cacheux, Victoria, Delwail, Vincent, Safar, Violaine, Gressin, Remy, Cheminant, Morgane, Hermine, Olivier, Macintyre, Elizabeth A., Le Gouill, Steven

“…Aim: Obinutuzumab (O) and Rituximab (R) have never been compared in a prospective randomized trial in mantle cell lymphoma (MCL). The LYMA-101 trial…”
Get full text

Exploring the Heterogeneity of Response to Blinatumomab in High-Risk Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: An Analysis from the QUEST Sub-Study of the Graall-2014/B Trial by Boissel, Nicolas, Huguet, Francoise, Leguay, Thibaut, Hunault, Mathilde, KIM, Rathana, Hicheri, Yosr, Passet, Marie, Chevallier, Patrice, Balsat, Marie, Maury, Sebastien, Thiebaut, Anne, Van Obbergh, Florence, Cluzeau, Thomas, Escoffre Barbe, Martine, Straetmans, Nicole, Konopacki, Johanna, Belhabri, Amine, Villate, Alban, Pasquier, Florence, Bouscary, Didier, Braun, Thorsten, Blum, Sabine, Cacheux, Victoria, Bonmati, Caroline, Wittnebel, Sebastian, Lhéritier, Véronique, Ifrah, Norbert, Graux, Carlos, Chalandon, Yves, Clappier, Emmanuelle, Dombret, Herve

“…Introduction. Adults with Philadelphia (Ph)-negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) benefit from blinatumomab (BLIN) in first-line…”
Get full text

Treatment and outcome of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults after relapse by Balsat, Marie, Cacheux, Victoria, Carre, Martin, Tavernier-Tardy, Emmanuelle, Thomas, Xavier

“…Despite the significant progress that has been made over the last years in the front-line treatment of Philadelphia (Ph) chromosome-positive acute…”
Get full text

Hypogammaglobulinemia during Rituximab Maintenance after Transplantation Is a Surrogate Marker for Disease Control in Patients with Mantle-Cell Lymphoma, an Analysis from the LyMa Trial by Bouard, Louise, Thieblemont, Catherine, Bouabdallah, Krimo, Gastinne, Thomas, Moreau, Anne, Masse, Sibylle, Gressin, Rémy, Oberic, Lucie, Caulier, Alexis, Gyan, Emmanuel, Cacheux, Victoria, Casasnovas, Olivier, Hermine, Olivier, Le Gouill, Steven

“…Introduction Rituximab maintenance (RM) (375mg/m2 per infusion every 2 months for 3 years) in transplanted patients with mantle-cell lymphomas (MCL) prolongs…”
Get full text

Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report by Cabannes-Hamy, Aurelie, Courtois, Lucien, Balsat, Marie, Simonin, Mathieu, Huguet, Françoise, Escoffre-Barbe, Martine, Pasquier, Florence, Bonmati, Caroline, Turlure, Pascal, Cluzeau, Thomas, Lebon, Delphine, Gehlkopf, Eve, Brissot, Eolia, Decroocq, Justine, Chevallier, Patrice, Chantepie, Sylvain, Cacheux, Victoria, Maury, Sebastien, Chebrek, Safia, Leguay, Thibaut, Fort, Melody, Mauz, Natacha, Lamarque, Mathlide, Mathilde, Hunault-Berger, Wickenhauser, Stefan, Frayfer, Jamilé, Banos, Anne, Tavernier, Emmanuelle, Caillot, Denis, Ronchetti, Anne Marie, Berthon, Celine, Lengline, Etienne, Lhéritier, Véronique, Dombret, Hervé, Marçais, Ambroise, Pinton, Antoine, Andrieu, Guillaume P, Boissel, Nicolas, Lhermitte, Ludovic, Asnafi, Vahid, Rousselot, Philippe

“…Introduction T-cell acute lymphoblastic leukemia (T-ALL) is an orphan disease diagnosed mostly in adolescent and young adults. In adult population, 5-10% of…”
Get full text

The Combination of Venetoclax and Tofacitinib Induced Hematological Responses in Patients with Relapse/ Refractory T-ALL with BCL2 Expression and Surface IL7R Expression or IL7R-Pathway Mutations (On behalf of the GRAALL) by Cabannes, Aurélie, Schmidt, Aline, Brissot, Eolia, Balsat, Marie, Maury, Sébastien, Isnard, Francoise, Chevallier, Patrice, Cacheux, Victoria, Cluzeau, Thomas, Graux, Carlos, Lhermitte, Ludovic, Dombret, Herve, Boissel, Nicolas, Asnafi, Vahid, Rousselot, Philippe

“…Background. We previously reported that IL7R-pathway genes are mutated in 29% of T-ALL and that surface IL7R is expressed in 53% of T-ALL (Rathana K et al…”
Get full text

Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study by Balayssac, David, Pereira, Bruno, Desmard, Juliette, Viers, Hugo, Barillon, Carole, Osseili, Ali, Chaleteix, Carine, Bachelerie, Marie, Pétorin, Caroline, Rouanet, Jacques, Cacheux, Victoria, Bailly, Sébastien, Bedhomme, Sabrina, Vennat, Brigitte, Bahadoor, Mohun, Merle, Patrick, Bay, Jacques-Olivier

“…Purpose. The growing choice of oral anticancer medications (OAMs) delivered in pharmacies puts the patients at the center of their own therapeutic management…”
Get full text

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l‐asparaginase: The GRAALL experience by Couturier, Marie‐Anne, Huguet, Françoise, Chevallier, Patrice, Suarez, Felipe, Thomas, Xavier, Escoffre‐Barbe, Martine, Cacheux, Victoria, Pignon, Jean‐Michel, Bonmati, Caroline, Sanhes, Laurence, Bories, Pierre, Daguindau, Etienne, Dorvaux, Véronique, Reman, Oumedaly, Frayfer, Jamile, Orvain, Corentin, Lhéritier, Véronique, Ifrah, Norbert, Dombret, Hervé, Hunault‐Berger, Mathilde, Tanguy‐Schmidt, Aline

“…Central nervous system (CNS) thrombotic events are a well‐known complication of acute lymphoblastic leukemia (ALL) induction therapy, especially with…”
Get full text

Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma by Lemonnier, François, Safar, Violaine, Beldi-Ferchiou, Asma, Cottereau, Anne-Ségolène, Bachy, Emmanuel, Cartron, Guillaume, Fataccioli, Virginie, Pelletier, Laura, Robe, Cyrielle, Letourneau, Audrey, Missiaglia, Edoardo, Fourati, Slim, Moles-Moreau, Marie-Pierre, Delmer, Alain, Bouabdallah, Reda, Voillat, Laurent, Becker, Stéphanie, Bossard, Céline, Parrens, Marie, Casasnovas, Olivier, Cacheux, Victoria, Régny, Caroline, Camus, Vincent, Delfau-Larue, Marie-Hélène, Meignan, Michel, de Leval, Laurence, Gaulard, Philippe, Haioun, Corinne

“…Angioimmunoblastic T-cell lymphoma (AITL) is a frequent T-cell lymphoma in the elderly population that has a poor prognosis when treated with cyclophosphamide,…”
Get full text

Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients by Balsat, Marie, Pillet, Sylvie, Tavernier, Emmanuelle, Cacheux, Victoria, Escuret, Vanessa, Moluçon-Chabrot, Cécile, Augeul-Meunier, Karine, Mirand, Audrey, Regagnon, Christel, Tinquaut, Fabien, Bousser, Véronique, Oriol, Mathieu, Guyotat, Denis, Salles, Gilles, Bay, Jacques-Olivier, Pozzetto, Bruno, Cornillon, Jérôme

“…•Active HHV-6 infection occurred in 11.2% of autologous stem cell recipients.•HHV-6 infection is associated with delayed neutrophils and platelets…”
Get full text

Lenalidomide in Combination with CHOP in Patients with Angioimmunoblastic T-Cell Lymphoma (AITL): Final Analysis of Clinical and Molecular Data of a Phase 2 Lysa Study by Lemonnier, Francois, Safar, Violaine, de Leval, Laurence, Cottereau, Anne Ségolène, Pelletier, Laura, Robe, Cyrielle, Bachy, Emmanuel, Cartron, Guillaume, Moles, Marie-Pierre, Letourneau, Audrey, Missiaglia, Edoardo, Delmer, Alain Jacques, Bouabdallah, Reda, Voillat, Laurent, Parrens, Marie, Casasnovas, Olivier, Cacheux, Victoria, Gressin, Remy, Tilly, Herve, Delfau, Marie-Helene, Meignan, Michel, Gaulard, Philippe, Haioun, Corinne

“…Introduction: AITL, one of the most common peripheral T-cell Lymphoma portends a poor prognosis. AITL is characterized by neoplastic T cells with a follicular…”
Get full text